This Combined Synopsis/Solicitation opportunity from Department Of Defense was posted on February 13, 2015. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Reagents and Consumables

Awarded

N00259-15-T-0085Federal

Submission Closed02/25/2015, 12:00:00 AM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325413

New

Federal

Blood Type IVD Reagents and Sera SupplyThis subcontract involves the supply of Blood Type IVD Reagents and Sera to prime contractors supporting Department of Veterans Affairs VISN 22 medical supply contracts. The scope of work includes the manufacture or distribution of ABO reverse typing cells, antibody screening cells, and antibody identification cells, as well as the provision of Lewis Blood Group Substance and full antigen profiles. All delivered reagents must be FDA compliant and accompanied by Certificates of Analysis or Conformance. The contract is managed by the Network Contract Office 22 under NAICS code 325413, with a response deadline set for November 16, 2026.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

6550--Blood Type IVD Reagents

Solicitation # 36C26227Q0043

The Department of Veterans Affairs, through the Network Contract Office 22, is seeking quotations for solicitation 36C26227Q0043 to establish a Blanket Purchase Agreement for blood type IVD reagents, supplies, and consumables for manual testing at VISN 22 facilities. The contract is structured with a 12-month base ordering period and four subsequent 12-month option periods, for a total potential duration of five years. This is a commercial products and services acquisition under FAR Part 12, with an emphasis on FDA regulatory compliance, potency requirements, and strict cold-chain and temperature-monitoring controls during shipment. All items must be quoted as F.O.B. destination and delivered Monday through Friday between 8am and 4pm. Award will be based on the best value to the government, evaluated through a comparative assessment of technical understanding, price, and quality, regulatory compliance, and product traceability. Technical evaluation considers the offeror's ability to provide a full antigen profile and their procedures for handling nonconforming or defective products. Pricing will be evaluated based on the total cost for the base period and all option periods, including a six-month price addition for the final performance period per FAR 52.217-8. Quotations must be submitted via email to the contract specialist by November 16, 2026, and must include a completed five-year pricing spreadsheet, a past performance questionnaire, and required certifications regarding telecommunications and trade agreements.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

6550--Abbott Architect i1000 Reagents and Consumables

Solicitation # 36C26227Q0073

Solicitation 36C26227Q0073 is a firm-fixed-price contract opportunity issued by the Department of Veterans Affairs, Network Contracting Office 22, for the procurement of Abbott Architect i1000 reagents and consumables. The scope includes the supply of FDA-approved reagents, controls, calibration materials, disposables, and consumable parts that must be fully compatible with the existing Architect i1000 analyzer without alteration. This acquisition is 100 percent set aside for small businesses under NAICS code 325413. The period of performance is scheduled from December 12, 2026, to December 11, 2027, with items to be ordered as needed. Performance will take place in Tucson, Arizona. The government will award the contract to the responsible offeror whose proposal is most advantageous, based on a combination of price and technical acceptability. Technical evaluation focuses on whether the offered products meet all salient characteristics, and any items deemed unacceptable will result in the entire offer being rejected. Offerors must provide clear evidence for any equal-to items and a Letter of Authorization from the Original Equipment Manufacturer to ensure products are not gray market or counterfeit. The submission deadline is November 13, 2026, at 1:00 PM Pacific Time. The contract also includes provisions for an option to increase quantity and a potential service extension of up to six months.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

Reagents and consumables for Roche immunostainers

Solicitation # 75N98027Q00026

Solicitation 75N98027Q00026 is a Firm-Fixed-Price Indefinite Delivery Indefinite Quantity (IDIQ) contract issued by the National Institutes of Health Office of Logistics and Operations. The objective is to procure proprietary reagents, kits, and consumables compatible with the National Cancer Institute's Roche Ventana Benchmark ULTRA and Benchmark Plus immunostainers. The contract includes a base year starting December 1, 2026, with four subsequent option years, carrying a minimum value of 20,000 dollars and a maximum value of 1.5 million dollars. The scope of work extends beyond supplies to include no-cost software upgrades, VConnect software coverage, and professional consultation from scientists and engineers. The contractor must adhere to strict quality and delivery standards, including overnight shipping using industry-best practices such as dry or wet ice, and ensuring all reagents have expiration dates exceeding 12 months from the shipping date. Deliveries are f.o.b. destination to Bethesda, Maryland, and must typically be completed within five days of a task order. Award will be based on a best value tradeoff evaluation considering technical proposal, equipment capability, delivery, and price. Offerors must provide a Unique Entity Identifier, Taxpayer Identification Number, and business size certification, with responses due by November 16, 2026.

National Institutes Of Health Olao

POSTED

DEADLINE

REAGENT POWDER — 6640015207401 — N0010426QEJ19

Solicitation # N0010426QEJ19

Solicitation N00104-26-Q-EJ19 is a fixed-price request for quotation issued by NAVSUP Weapons Systems Support for the procurement of Reagent Powder (NSN 6640-01-520-7401), manufactured by Idexx Distribution Corp. The requirement consists of 60 packages, with each package containing 200 units. Delivery is scheduled incrementally in four shipments of 15 packages each, starting on or around April 15, 2027, with subsequent deliveries every 90 days. The items are shelf-life sensitive with a 12-month duration, and they must be supplied with at least 85 percent of their shelf life remaining at the time of shipment. The contract mandates strict adherence to MIL-STD-129 for marking and labeling, and packaging must comply with MIL-STD-2073-1 or ASTM D3951-18 depending on the destination. Key deliverables include a Certificate of Compliance per DI-MISC-81356 and a cure date certificate per DI-MISC-81318, both submitted at the time of material delivery. Award will be made to the responsible offeror providing the lowest priced, technically acceptable offer. Inspection and acceptance are designated at the origin, and the contractor is required to maintain a government-acceptable inspection system. Additionally, the contract prohibits the intentional addition of mercury and requires compliance with hazardous material identification and safety data sheet regulations.

Navsup Weapon Systems Support Mech

POSTED

DEADLINE

TEST KIT, CORONAVIRUS D

Solicitation # SPE2DS-27-T-1071

Solicitation SPE2DS-27-T-1071, issued by the DLA Troop Support Medical Supply Chain, is for the procurement of one case of Abbott BinaxNOW COVID-19 Antigen self-test kits for over-the-counter, at-home use. Each case contains 12 kits with 2 tests per kit. The items must be stored between 2-30 degrees Celsius and have a non-extendable shelf life of 12 months, with no more than one month elapsed from the date of manufacture to the date of delivery. Delivery is required within 20 days after receipt of the order, with a final delivery date of October 30, 2026, to the USS IDAHO (SSN 799). The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and requires labels to include the contract or lot number and the date of manufacture, expiration, or retest. Packaging must be commercial, utilizing sealed unit containers and suitable exterior shipping containers. Inspection and acceptance will occur at the destination per FAR 52.246-2. Administrative requirements include the use of the Wide Area Workflow system for electronic invoicing and compliance with various FAR and DFARS clauses regarding cybersecurity, the Buy American Act, and the prohibition of covered defense telecommunications equipment. Quotations are due by November 3, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CULTURE MEDIUM, THAYER-

Solicitation # SPE2DS-27-T-1066

Solicitation SPE2DS-27-T-1066 is a request for quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of one package of Thayer-Martin Modified (MTM II) Agar culture medium, identified by NSN 6550-01-711-1542. This dark brown, ready-to-use plated medium is specifically designed for the isolation of pathogenic Neisseria from specimens containing mixed flora of bacteria and fungi. The product is delivered in packages of 100 plates and requires strict refrigeration storage between 2 to 8 degrees Celsius (36 to 46 degrees Fahrenheit) and must not be frozen. The contract mandates a non-extendable shelf life of three months, with a requirement that no more than 14 days elapse between the date of manufacture and the date of delivery to the government. Delivery is set for JBER, Alaska, with a required delivery date of October 27, 2026, under FOB Destination terms. Packaging must be commercial and sealed to prevent damage, with marking adhering to Medical Marking Standard No. 1 and shelf-life labels following MMS1C. Administrative requirements include electronic invoicing via the Wide Area WorkFlow system and compliance with various FAR and DFARS clauses, including the Buy American Act, Berry Amendment, and safeguarding of covered defense information. Evaluation will consider technical data for any alternate products offered and may include HUBZone price evaluation preferences. Inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of ALBAcyte Blood Bank ReagentsThis subcontract involves the manufacture and supply of specialized ALBAcyte blood bank reagents for prime contractors supporting the Department of Veterans Affairs North Texas Health Care System. The scope of work includes the delivery of A1, A2, B, IgG Sensitized, Antibody ID Panels, and C3 Coated RBCs. To ensure product efficacy, the contractor must utilize shipping containers that maintain reagent integrity and adhere to a defined Quality Plan and FDA approval standards. Deliveries are to be made FOB Destination to the Transfusion Medicine Unit located in Dallas, Texas. The contract is categorized under NAICS code 325413 and is managed through the Department of Veterans Affairs Network Contract Office 17.

257-NETWORK Contract Office 17 (36C257)

POSTED

DEADLINE

6550--Blood Bank Reagents

Solicitation # 36C25727Q0065

The Department of Veterans Affairs VA North Texas Health Care System is issuing a Sources Sought Notice to identify qualified vendors capable of providing blood bank reagents for the Transfusion Medicine Unit in Dallas, Texas. These reagents, including ALBAcyte A1, A2, B, IgG Sensitized, Antibody ID Panels, and C3 Coated Red Blood Cells, are essential for manual blood typing and serum antibody detection used in cross-matching blood for transfusions. The anticipated acquisition strategy includes a base year starting May 1, 2027, with four subsequent one-year option periods extending through April 30, 2032. To be considered, vendors must be FDA approved, provide documentation of such approval, and maintain a defined quality plan with adequate supply availability. All shipments must be FOB Destination, and the contractor is responsible for providing appropriate shipping containers. Interested vendors must submit an electronic capability statement in PDF or Word format, including the place of manufacture for all listed reagents, to the designated contract specialist by November 5, 2026, at 9:00 AM CST. This notice is for market research purposes only to determine the appropriate acquisition strategy, such as a small business set-aside, and does not constitute a formal solicitation.

257-NETWORK Contract Office 17 (36C257)

POSTED

DEADLINE

6505--DRESSING, DRAWTEX 4IN X 4IN (VA-27-00014447)

Solicitation # 36C77027Q0015

The Department of Veterans Affairs, National CMOP Office, is conducting market research through a Sources Sought announcement to identify qualified sources for the procurement of Drawtex Dressing, 4in X 4in, packaged as 10ct per box. This action is for market research purposes only and is not a formal solicitation for quotes; therefore, no contract will be awarded based on this specific announcement. The place of performance is located in Ladson, South Carolina, and the primary point of contact is Contract Specialist Claudine Challinor. Interested respondents must submit their information via email by November 3, 2026. Required details include the company's SAM Unique ID Number, business size (Small, Large, SDVOSB, or VOSB), and point of contact information. Specifically, the government is seeking to determine if the respondent is the manufacturer, the manufacturer's product number, and the place of manufacturing. If the respondent is not the manufacturer, they must provide a letter of authorization from the original equipment manufacturer or provide detailed product literature and specifications for alternative products that demonstrate similarities to the Drawtex hydro conductive wound dressing.

National Cmop Office (36C770)

POSTED

DEADLINE

BCL27*392462-AccuSet HIV Verification Panel-STD Testing

Solicitation # SRC0000037402

Solicitation SRC0000037402 is issued by the Alabama Clinical Laboratory Services for the procurement of AccuSet HIV Verification Panels for STD testing. The contract allows for a total value of up to 25,000 dollars and may be renewed annually for a maximum period of five years from the effective date. Responses must be submitted electronically through the Alabama Buys portal by the deadline of November 2, 2026. Award decisions will be based on pricing, with the State reserving the right to analyze cost realism and price reasonableness, and may require proof of professional licenses, certificates of insurance, and manufacturer reseller authorizations. The agreement is governed by the Code of Alabama 1975 and the Universal Commerce Code, with the City of Montgomery serving as the sole venue for litigation. The State of Alabama is exempt from sales tax and maintains the right to inspect all products before formal acceptance. Suppliers must certify they are not debarred or suspended, are not engaged in prohibited boycotts, and are compliant with Alabama state and local tax registrations. Payment will be handled via electronic methods, including P-cards and EFT, and the contract is subject to appropriation of funds according to state law.

Clinical Laboratory Services

POSTED

DEADLINE

6550--Optilite analyzer reagents

Solicitation # 36C26227Q0052

The Department of Veterans Affairs, Southern Arizona Healthcare System, is soliciting a Firm-Fixed Price Blanket Purchase Agreement under solicitation 36C26227Q0052 for the procurement of FDA-approved reference testing reagents and consumables validated for use on the Optilite analyzer. The scope includes specific items such as Freelite Kappa, Freelite Lambda, and Ceruloplasmin reagents, as well as TENCELL cuvettes and sample cups. To ensure system performance and safety, all materials must be manufactured by Binding Site Laboratories, and substitutions are prohibited. The contract is issued as a full and open competition under NAICS code 325413, with a total estimated period of performance of sixty months, consisting of a base period from November 9, 2026, to November 8, 2027, followed by four one-year option periods. The award will be granted to the responsible offeror whose proposal is most advantageous to the government, based on a technical acceptability review of the Statement of Work and the lowest price. Deliveries are required to be made to various VA Medical Centers across Arizona, California, and New Mexico, with standard orders delivered within four working days of placement. All shipments must be destination-based, with the vendor assuming all shipping costs and adhering to strict packaging standards to prevent damage. Invoicing is handled electronically through the Department of Veterans Affairs Financial Services Center in accordance with the Prompt Payment Act. Quotes must be submitted via email to Contract Specialist Carlos Magana by November 4, 2026.

262-NETWORK Contract Office 22 (36C262)

POSTED

4 days ago

DEADLINE

in 4 days

AI Contract Overview

The Naval Medical Center San Diego is soliciting quotations for a variety of commercial reagents and consumables under solicitation number N00259-15-T-0085. This requirement is being pursued on a sole source basis from Diagnostica Stago Inc., as they are the exclusive manufacturer of the reagents and consumables compatible with the hemostasis instruments currently utilized by the facility. The acquisition falls under NAICS code 325413 and includes seventeen distinct line items ranging from controls and cleaners to specialized syringes and power managers. Interested bidders must submit their quotations electronically to the designated contract specialist by February 24, 2015, at 4:00 pm Pacific Standard Time. To be eligible for award, contractors must be registered in the System for Award Management and complete the required offeror representations and certifications for commercial items. Proposals will be evaluated based on technical capability and price, with delivery designated for the Naval Medical Center San Diego loading dock.

General Info

Agency

Department Of Defense → Naval Medical Center San Diego Ca

Contract Value

$80,611.44

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Place of Performance

CA, USA

Set-Aside

NONE

Awardee

DIAGNOSTICA STAGO INC

Award Issued Date

03/09/2015, 12:00:00 AM UTC

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseAwarded

PostedFeb 13

Combined Synopsis

AwardedMar 9

Contract was awarded

Submission Closed

02/25/2015, 12:00:00 AM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → Naval Medical Center San Diego Ca

Contacts1 person available

OfficeSAN DIEGO, CA, 92134-5000, USA

Organization / AgencyDepartment Of Defense → Naval Medical Center San Diego Ca

Office AddressSAN DIEGO, CA, 92134-5000, USA

Contacts

Reynaldo R. DeVeraContract Specialist

contact@example.gov

+1 (555) 000-0000

Full Description

The proposed contract action is for commercial item, which the Naval Medical Center San Diego intends to solicit this requirement on a sole source basis to DIAGNOSTICA STAGO INC, under the authority of Far 13.106-1 (b) (1) (i). This is a combined solicitation/synopsis for commercial items, prepared in accordance with the format in FAR subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes only solicitation, quotations are being requested and a written solicitation will not be issued. The solicitation number, N00259-15-T-0085 is issued as a request for quotation (RFQ). The North American Industry Classification System (NAICS) Code for this acquisition is 325413. All interested bidders shall submit quotations electronically by email to contact@example.gov or by facsimile at +1 (555) 000-0000, attention Reynaldo de Vera. E-mail submissions are limited to 2MB. The submitter should confirm receipt of facsimile and email submissions. Quotations are due on or before February 24, 2015 at 04:00 pm Pacific Standard Time to be considered responsive. CLIN 0001 STA-Liatest Controls, Cat # 526 QTY 28 KT $_______ CLIN 0002 STA-Coag Controls N & ABN, Cat # 676 QTY $_______ CLIN 0003 STA-Liatest D-Dimer 6x6ml Cat # 0515 QTY 45 EA $_______ CLIN 0004 STA Owren-Koller, Cat # 360 QTY 9 EA $_______ CLIN 0005 STA Calcium Chloride, Cat # 367 QTY 6 EA $_______ CLIN 0006 STA-R Cleaner Solution, Cat # 0973 QTY 29 BX $_______ CLIN 0007 STA-R Needle # 1 P/N S-999BA30, Cat # 39249 QTY 5 EA $_______ CLIN 0008 STA Desorb U Solution, Cat # 975 QTY 64 KT $_______ CLIN 0009 STA-r Teflon Syringe Tip & Orings, Cat # 27530, P/N: S-99870 QTY 8 EA $_______ CLIN 0010 STA Maxi Reducer, Cat # 801 QTY 14 EA $_______ CLIN 0011 STA Microtainers, 500 ea, Cat # 741, P/N: 0741 QTY 3 EA $_______ CLIN 0012 STA PTT Automate, Cat # 595 QTY 42 EA $_______ CLIN 0013 STA Neoplastine CL Plus Cat # 667 QTY 48 EA $_______ CLIN 0014 STA Fibrinogen 5, Cat # 674 QTY 10 EA $_______ CLIN 0015 STA Syringe & O Ring, Cat # 27538, P/N: S-9987F60 QTY 6 EA $_______ CLIN 0016 Uninterrupted Power Manager, P/N: 80617 QTY 2 EA $_______ CLIN 0017 Soft Style pk of 10, Cat # 80343 QTY 3 EA $_______ Under the authority of FAR 13.106-1(b), sole source justification is based on Diagnostica Stago Inc. being the only company that manufactures exclusive reagents and consumables for the hemostasis instruments currently use at NMCSD. Contractor must be registered to the System for Award Management (SAM) prior to award. The website address for SAM registration is www.sam.gov Contractor MUST complete FAR 52.212-3, Offeror Representations and Certifications - Commercial Items, when submitting a proposal. The website address is http://www.acquisition.gov. DELIVERY ADDRESS: Naval Medical Center San Diego, Loading Dock 1, 34800 Bob Wilson Drive, San Diego, CA 92134 The solicitation document and incorporated provisions and clauses are those in effect through FAC 2005-78 and DFARS Change Notice 20141226. This acquisition incorporates the following FAR clauses: 52.204-7 System for Award Management (JUL 2013) 52.204-10 Reporting Executive Compensation and First-Tier Subcontract Awards (JUL2013) 52.204-13 System for Award Management Maintenance (JUL 2013) 52.209-6 Protecting the Government's Interest When Subcontracting With Contractors Debarred, Suspended, or Proposed for Debarment (AUG 2013) 52.212-1 Instruction to Offerors-Commercial Item (APR 2014) 52.212-2 Evaluation-Commercial Items (OCT 2014).The following factors shall be used to evaluate offers in descending order: 1) Technical Capability; 2) Price 52.212-3 Offeror Representations and Certification--Commercial Items (DEC 2014) 52.212-4 Contract Terms and Conditions--Commercial Items (DEC 2014) 52.212-5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders--Commercial Items (DEC 2014) 52.219-28 Post Award Small Business Program Representative (JUL 2013) 52.222-3 Convict Labor (JUN 2003) 52.222-19 Child Labor -- Cooperation with Authorities and Remedies (JAN 2014) 52.222-26 Equal Opportunity (MAR 2007) 52.222.36 Equal Opportunity for Workers with Disabilities (JUL 2014) 52.223-18 Encouraging Contractor Policies to Ban Text Messaging while Driving (AUG 2011) 52.225-13 Restrictions on Certain Foreign Purchases (JUN 2008) 52.232-33 Payment by Electronic Funds Transfer - System for Award Management (JUL 2013) 52.252-2 Clauses Incorporated By Reference (FEB 1998) 252.225-7001 Buy American And Balance of Payments Program (NOV 2014) 252.225-7002 Qualifying Country Sources As Subcontractors (DEC 2012) 252.232-7003 Electronic Submission of Payment Requests (JUN 2012)) All responsible sources may submit a quotation which shall be considered by the agency.